Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:653

Purdue Pharma L.P. - Strategic SWOT Analysis Review

Purdue Pharma L.P. - Strategic SWOT Analysis Review

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $125.00
Meta Description Purdue Pharma L.P. (Purdue) is a privately held, US-based pharmaceutical company. It is one of the leading developers of pharmacologic therapies for the treatment and management of pain. The company undertakes the research, development, manufacture and ma
Publisher GlobalData
Date of Report Dec 3, 2013
Quick Overview
Summary

Purdue Pharma L.P. (Purdue) is a privately held, US-based pharmaceutical company. It is one of the leading developers of pharmacologic therapies for the treatment and management of pain. The company undertakes the research, development, manufacture and marketing of prescription medicines and over-the-counter (OTC) medicines and healthcare products. The company specializes in research on persistent pain. Purdue's research and development (R&D) efforts focus on the advancement of technologies in drug delivery and development of innovative medicines for the treatment of pain and other conditions. The company operates three facilities in North Carolina and New Jersey.

Purdue Pharma L.P. Key Recent Developments

Feb 25, 2013: Purdue Pharma Increases Adoption Of Medidata Clinical Cloud To Strengthen R&D OperationsnOct 23, 2012: NASCSA Receives $200,000 Grant From Purdue Pharma To Support State Prescription Drug Monitoring Programs
Sep 20, 2012: American Medical Association Foundation Awards $190,000 To 25 Organizations To Promote Prescription Drug Safety
Jan 26, 2012: Unity Management Group Subsidiary Announces First Contract Of 2012 With Purdue Pharma And Novartis

GlobalData’s Purdue Pharma L.P. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Section 1 - About the Company 4
Purdue Pharma L.P. - Key Facts 4
Purdue Pharma L.P. - Key Employees 5
Purdue Pharma L.P. - Key Employee Biographies 6
Purdue Pharma L.P. - Major Products and Services 7
Purdue Pharma L.P. - Pharmaceutical Pipeline Products Data 8
Purdue Pharma L.P., Pipeline Products by Therapy Area 8
Purdue Pharma L.P., Pipeline Products by Development Phase 9
Purdue Pharma L.P. - History 11
Purdue Pharma L.P. - Company Statement 13
Purdue Pharma L.P. - Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Purdue Pharma L.P. - Key Manufacturing Facilities 15
Affiliate 15
Section 2 – Company Analysis 16
Purdue Pharma L.P. - Business Description 16
Purdue Pharma L.P. - Corporate Strategy 17
Purdue Pharma L.P. - SWOT Analysis 18
SWOT Analysis - Overview 18
Purdue Pharma L.P. - Strengths 18
Strength - Focused Research and Development Activities 18
Strength - Strong Product Portfolio 18
Strength - Manufacturing and Marketing Facilities 18
Purdue Pharma L.P. - Weaknesses 18
Weakness - Geographical Concentration 18
Weakness - Law Suits 19
Purdue Pharma L.P. - Opportunities 19
Opportunity - Strategic Alliances 19
Opportunity - New Product Launches 19
Opportunity - Changing Demographics 19
Purdue Pharma L.P. - Threats 19
Threat - Cost Containment Pressures 19
Threat - Uncertain R&D Outcomes 20
Threat - Competitive Pressures 20
Purdue Pharma L.P. - Key Competitors 21
Section 3 – Company’s Lifesciences Financial Deals and Alliances 22
Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 22
Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 23
Purdue Pharma L.P., Recent Deals Summary 24
Section 4 – Company’s Recent Developments 25
Purdue Pharma L.P., Recent Developments 25
Feb 25, 2013: Purdue Pharma Increases Adoption Of Medidata Clinical Cloud To Strengthen R&D Operations 25
Oct 23, 2012: NASCSA Receives $200,000 Grant From Purdue Pharma To Support State Prescription Drug Monitoring Programs 25
Sep 20, 2012: American Medical Association Foundation Awards $190,000 To 25 Organizations To Promote Prescription Drug Safety 26
Jan 26, 2012: Unity Management Group Subsidiary Announces First Contract Of 2012 With Purdue Pharma And Novartis 26
Section 5 – Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Purdue Pharma L.P., Key Facts 4
Purdue Pharma L.P., Key Employees 5
Purdue Pharma L.P., Key Employee Biographies 6
Purdue Pharma L.P., Major Products and Services 7
Purdue Pharma L.P., Number of Pipeline Products by Therapy Area 8
Purdue Pharma L.P., Number of Pipeline Products by Development Stage 9
Purdue Pharma L.P., Pipeline Products By Therapy Area and Development Phase 10
Purdue Pharma L.P., History 11
Purdue Pharma L.P., Other Locations 14
Purdue Pharma L.P., Key Manufacturing Facilities 15
Purdue Pharma L.P., Affiliate 15
Purdue Pharma L.P., Key Competitors 21
Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 22
Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 23
Purdue Pharma L.P., Recent Deals Summary 24

List of Figures
Purdue Pharma L.P., Pipeline Products by Therapy Area 8
Purdue Pharma L.P., Pipeline Products by Development Phase 9
Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 22
Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 23




...